- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2059-3635
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The intracellular signalosome of PD-L1 in cancer cells ; volume:3 ; number:1 ; day:28 ; month:9 ; year:2018 ; pages:1-9 ; date:12.2018
Signal transduction and targeted therapy ; 3, Heft 1 (28.9.2018), 1-9, 12.2018
- Creator
-
Escors, David
- Contributor
-
Gato-Cañas, María
Zuazo, Miren
Arasanz, Hugo
García-Granda, María Jesus
Vera, Ruth
Kochan, Grazyna
SpringerLink (Online service)
- DOI
-
10.1038/s41392-018-0022-9
- URN
-
urn:nbn:de:101:1-2018110520414782530769
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Escors, David
- Gato-Cañas, María
- Zuazo, Miren
- Arasanz, Hugo
- García-Granda, María Jesus
- Vera, Ruth
- Kochan, Grazyna
- SpringerLink (Online service)
Other Objects (12)
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Optimized PD-L1 scoring of gastric cancer
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
PD-L1 degradation pathway and immunotherapy for cancer
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
Clinical applications of PD-L1 bioassays for cancer immunotherapy
Autophagy inhibition enhances PD-L1 expression in gastric cancer
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Comparing VIP and PD‐L1 expression as cancer biomarkers
PD-L1 blockade immunotherapy rewires cancer-induced emergency myelopoiesis
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Optimized PD-L1 scoring of gastric cancer
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
PD-L1 degradation pathway and immunotherapy for cancer
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
Clinical applications of PD-L1 bioassays for cancer immunotherapy
Autophagy inhibition enhances PD-L1 expression in gastric cancer
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Comparing VIP and PD‐L1 expression as cancer biomarkers
PD-L1 blockade immunotherapy rewires cancer-induced emergency myelopoiesis
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Optimized PD-L1 scoring of gastric cancer
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
PD-L1 degradation pathway and immunotherapy for cancer
Prognostic value of soluble PD-L1 and exosomal PD-L1 in advanced gastric cancer patients receiving systemic chemotherapy
PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
Clinical applications of PD-L1 bioassays for cancer immunotherapy
Autophagy inhibition enhances PD-L1 expression in gastric cancer
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Comparing VIP and PD‐L1 expression as cancer biomarkers